Genedata Adds NVIDIA Protein Design AI to Drug Discovery
Genedata, a Danaher company that develops software for biopharmaceutical research and development, has integrated NVIDIA’s RFD4-Proteina binder-design model into its AI-enabled discovery workflows. The integration is designed to connect AI-generated protein designs with laboratory experiments and scientific data, allowing researchers to evaluate candidate molecules, capture experimental outcomes and use those results to guide subsequent design…
